Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
Related Posts
Medicare or Medicare Advantage? A Guide for 2025
Open enrollment for Medicare plans began on Oct. 15 and ends on Dec. 7. Here’s what older Americans need to…
Unvaccinated Child Dies of Measles in Texas, Officials Say
At least 124 cases of measles have been identified in Texas since late January, mostly among children and teenagers who…
Orcas Are Considered One Species. Should They Be?
Killer whales are some of the most cosmopolitan creatures on the planet, swimming through every one of the world’s oceans.…